Literature DB >> 22752312

The negative impact of attention-deficit/hyperactivity disorder on occupational health in adults and adolescents.

Thomas Küpper1, Jan Haavik, Hans Drexler, Josep Antoni Ramos-Quiroga, Detlef Wermelskirchen, Christin Prutz, Barbara Schauble.   

Abstract

PURPOSE: To review the negative effects of attention-deficit/hyperactivity disorder (ADHD) in adolescence and adulthood on work productivity and occupational health.
METHODS: A review of the MEDLINE database was carried out to identify direct and indirect effects of ADHD on work, employment and occupational health.
RESULTS: ADHD is associated with higher levels of unemployment versus controls. Adults with ADHD who are employed experience workplace impairment and reduced productivity, as well as behavioural issues such as irritability and low frustration tolerance. Adults with ADHD are also at increased risk of accidents, trauma and workplace injuries, particularly traffic accidents. Indirect effects of ADHD on occupational health include reduced educational achievement and increased rates of substance abuse and criminality. Overall, ADHD in adults has a substantial economic impact as a result of absenteeism and lost productivity. Psychoeducation, combined with stimulant medications if necessary, is recommended as first-line treatment for adults with ADHD. Limited data available suggest that stimulant treatment can improve work productivity and efficacy, and reduce the risks associated with driving, although further studies are necessary.
CONCLUSIONS: ADHD can affect the ability to gain and maintain employment and to work safely and productively. As ADHD is a treatable condition, patients, employers and physicians have a role to play in ensuring optimal occupational health.

Entities:  

Mesh:

Year:  2012        PMID: 22752312     DOI: 10.1007/s00420-012-0794-0

Source DB:  PubMed          Journal:  Int Arch Occup Environ Health        ISSN: 0340-0131            Impact factor:   3.015


  111 in total

Review 1.  Clinical assessment and diagnosis of adults with attention-deficit/hyperactivity disorder.

Authors:  Jan Haavik; Anne Halmøy; Astri J Lundervold; Ole Bernt Fasmer
Journal:  Expert Rev Neurother       Date:  2010-10       Impact factor: 4.618

Review 2.  College students with ADHD: current status and future directions.

Authors:  George J DuPaul; Lisa L Weyandt; Sean M O'Dell; Michael Varejao
Journal:  J Atten Disord       Date:  2009-07-20       Impact factor: 3.256

Review 3.  A physician's guide to helping patients with ADHD find success in the workplace.

Authors:  Alice R Mao; Matthew Brams; Thomas Babcock; Manisha Madhoo
Journal:  Postgrad Med       Date:  2011-09       Impact factor: 3.840

4.  Relative benefits of stimulant therapy with OROS methylphenidate versus mixed amphetamine salts extended release in improving the driving performance of adolescent drivers with attention-deficit/hyperactivity disorder.

Authors:  Daniel J Cox; R Lawrence Merkel; Melissa Moore; Frances Thorndike; Carrie Muller; Boris Kovatchev
Journal:  Pediatrics       Date:  2006-09       Impact factor: 7.124

Review 5.  A review of driving risks and impairments associated with attention-deficit/hyperactivity disorder and the effects of stimulant medication on driving performance.

Authors:  Russell A Barkley; Daniel Cox
Journal:  J Safety Res       Date:  2007-02-15

6.  History of attention-deficit hyperactivity disorder symptoms and opioid dependence: a controlled study.

Authors:  Eugen Davids; Ulla von Bünau; Michael Specka; Barbara Fischer; Norbert Scherbaum; Markus Gastpar
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2005-02       Impact factor: 5.067

7.  A comparison of the efficacy of medications for adult attention-deficit/hyperactivity disorder using meta-analysis of effect sizes.

Authors:  Stephen V Faraone; Stephen J Glatt
Journal:  J Clin Psychiatry       Date:  2009-12-29       Impact factor: 4.384

8.  Driving-related risks and outcomes of attention deficit hyperactivity disorder in adolescents and young adults: a 3- to 5-year follow-up survey.

Authors:  R A Barkley; D C Guevremont; A D Anastopoulos; G J DuPaul; T L Shelton
Journal:  Pediatrics       Date:  1993-08       Impact factor: 7.124

9.  Meta-analysis of the efficacy of methylphenidate for treating adult attention-deficit/hyperactivity disorder.

Authors:  Stephen V Faraone; Thomas Spencer; Megan Aleardi; Christine Pagano; Joseph Biederman
Journal:  J Clin Psychopharmacol       Date:  2004-02       Impact factor: 3.153

Review 10.  Impact of comorbidity in adults with attention-deficit/hyperactivity disorder.

Authors:  Joseph Biederman
Journal:  J Clin Psychiatry       Date:  2004       Impact factor: 4.384

View more
  39 in total

1.  Memory-guided force output is associated with self-reported ADHD symptoms in young adults.

Authors:  Kristina A Neely; Amanda P Chennavasin; Arie Yoder; Genevieve K R Williams; Eric Loken; Cynthia L Huang-Pollock
Journal:  Exp Brain Res       Date:  2016-07-09       Impact factor: 1.972

2.  Executive Functions among Traumatic Injury Patients: Comparison of Normal Individuals and those with Attention Deficit Hyperactivity Disorder.

Authors:  Arash Mani; Rohallah Rostami; Ali Alavi Shoushtari; Shahram Paydar
Journal:  Bull Emerg Trauma       Date:  2014-07

3.  Variability in Positive and Negative Affect Among Adolescents with and without ADHD: Differential Associations with Functional Outcomes.

Authors:  Rosanna Breaux; Joshua M Langberg; Courtney S Swanson; Hana-May Eadeh; Stephen P Becker
Journal:  J Affect Disord       Date:  2020-05-25       Impact factor: 4.839

4.  Deficits in inhibitory force control in young adults with ADHD.

Authors:  Kristina A Neely; Peiyuan Wang; Amanda P Chennavasin; Shaadee Samimy; Jacqueline Tucker; Andrea Merida; Koraly Perez-Edgar; Cynthia Huang-Pollock
Journal:  Neuropsychologia       Date:  2017-03-09       Impact factor: 3.139

Review 5.  Attention-deficit/hyperactivity disorder and adverse health outcomes.

Authors:  Joel T Nigg
Journal:  Clin Psychol Rev       Date:  2012-12-07

6.  Functioning Assessment Short Test (FAST): validity and reliability in adults with attention-deficit/hyperactivity disorder.

Authors:  Sofía Rotger; Vanesa Richarte; Mariana Nogueira; Montse Corrales; Rosa Bosch; Raquel Vidal; Lidia Marfil; Sergi Valero; Eduard Vieta; José Manuel Goikolea; Imma Torres; Adriane Rosa; María Mur; Miguel Casas; Josep Antoni Ramos-Quiroga
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-04-08       Impact factor: 5.270

7.  The descriptive epidemiology of DSM-IV Adult ADHD in the World Health Organization World Mental Health Surveys.

Authors:  John Fayyad; Nancy A Sampson; Irving Hwang; Tomasz Adamowski; Sergio Aguilar-Gaxiola; Ali Al-Hamzawi; Laura H S G Andrade; Guilherme Borges; Giovanni de Girolamo; Silvia Florescu; Oye Gureje; Josep Maria Haro; Chiyi Hu; Elie G Karam; Sing Lee; Fernando Navarro-Mateu; Siobhan O'Neill; Beth-Ellen Pennell; Marina Piazza; José Posada-Villa; Margreet Ten Have; Yolanda Torres; Miguel Xavier; Alan M Zaslavsky; Ronald C Kessler
Journal:  Atten Defic Hyperact Disord       Date:  2016-11-19

8.  The World Health Organization Adult Attention-Deficit/Hyperactivity Disorder Self-Report Screening Scale for DSM-5.

Authors:  Berk Ustun; Lenard A Adler; Cynthia Rudin; Stephen V Faraone; Thomas J Spencer; Patricia Berglund; Michael J Gruber; Ronald C Kessler
Journal:  JAMA Psychiatry       Date:  2017-05-01       Impact factor: 21.596

9.  Persistence of Parent-Reported ADHD Symptoms From Childhood Through Adolescence in a Community Sample.

Authors:  Joseph R Holbrook; Steven P Cuffe; Bo Cai; Susanna N Visser; Melinda S Forthofer; Matteo Bottai; Andrew Ortaglia; Robert E McKeown
Journal:  J Atten Disord       Date:  2014-07-03       Impact factor: 3.256

10.  Comorbidity and sociodemographic characteristics of adult autism spectrum disorder and attention deficit hyperactivity disorder: epidemiological investigation in the World Mental Health Japan 2nd Survey.

Authors:  Maki Umeda; Haruki Shimoda; Karin Miyamoto; Hanako Ishikawa; Hisateru Tachimori; Tadashi Takeshima; Norito Kawakami
Journal:  Int J Dev Disabil       Date:  2019-03-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.